The amazing osteocyte.

Bonewald LF. · 2011

Read The amazing osteocyte. by Bonewald LF. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3179345.txt.

Introduction

Lynda Bonewald celebrated a long-underestimated bone cell in a 2011 review in the Journal of Bone and Mineral Research. Osteocytes, embedded in mineralised bone, make up nearly all bone cells and can live for decades, yet were dismissed as passive placeholders. A decade of molecular work overturned that view, and this review gathers the transformation.

Osteocytes now appear as conductors of bone renewal, directing both bone-building and bone-eating cells, and as hormone sources reaching kidney, muscle, and beyond. They manage phosphate and calcium supply and can even remodel the walls of their own chambers. Their death with age and under steroid or inflammatory treatment leaves empty pits and weakens renewal. Keeping osteocytes alive, Bonewald argues, is central to bone and whole-body health.

Catalog record

CREATORBonewald LF.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3179345

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Amazing Osteocyte By Lynda F Bonewald Published in: Journal of Bone and Mineral Research DOI: 10.1002/jbmr.320 ABSTRACT The last decade has provided a virtual explosion of data on the molecular biology and function of osteocytes. Far from being the “passive placeholder in bone,” this cell has been found to have numerous functions, such as acting as an orchestrator of bone remodeling through regulation of both osteoclast and osteoblast activity and also functioning as an endocrine cell. The osteocyte is a source of soluble factors not only to target cells on the bone surface but also to target distant organs, such as kidney, muscle, and other tissues. This cell plays a role in both phosphate metabolism and calcium availability and can remodel its perilacunar matrix. Osteocytes compose 90% to 95% of all bone cells in adult bone and are the longest lived bone cell, up to decades within their mineralized environment. As we age, these cells die, leaving behind empty lacunae that frequently micropetrose. In aged bone such as osteonecrotic bone, empty lacunae are associated with reduced remodeling. Inflammatory factors such as tumor necrosis factor and glucocorticoids used to treat inflammatory disease induce osteocyte cell death, but by different mechanisms with potentially different outcomes. Therefore, healthy, viable osteocytes are necessary for proper functionality of bone and other organs. © 2011 American Society for Bone and Mineral Research. PIONEERS IN THE STUDY OF OSTEOCYTES Before the introduction of PubMed and easy access to papers, some of the earliest observations regarding osteocytes, like the cells themselves, laid buried and difficult to find. My colleagues and I, like others, made assumptions that many of our observations were new and novel until these publications were made readily available. For example, over 100 years ago, it was postulated that osteocytes could remodel their extracellular matrix(1); over 40 years ago, it was thought that osteocytes were responsive to parathyroid hormone,(2) could remodel bone(3) and could express tartrate-specific acid phosphatase(4); and over 20 years ago, it was said that osteocytes were mechanosensory cells.(5) Marotti and Palumbo drew beautiful diagrams to illustrate their theories regarding osteocyte function and communication.(6) Histology was the major tool used by these early pioneers to generate their theories. Peter Nijweide was the first to isolate avian osteocytes.(7) Some of the earliest videos of bone cells including osteocytes were recorded by Kumegawa and colleagues.(8) With new technology, such as molecular and transgenic approaches, imaging, cell lines, systems biology, advanced instrumentation, and others, a dramatic increase in information on osteocyte biology has occurred in the last decade, leading to validation of old theories and the generation of new ones. These are highlighted in this review. OSTEOCYTES AS DESCENDANTS OF OSTEOBLASTS The osteocyte, defined as a cell located within the bone matrix, is descended from mesenchymal stem cells through osteoblast differentiation (Fig. 1). It was proposed by Manolagas(9) that the matrix-producing osteoblast either can become an osteocyte, a lining cell, or can undergo programmed cell death. His theories were based on the observations of another very early pioneer, Michael Parfitt, who proposed that osteoblasts must die by apoptosis.(10) Osteocytogenesis has been thought to be a passive process whereby a subpopulation of osteoblasts becomes passively encased in osteoid that passively mineralizes. It was theorized that an osteoblast-producing matrix/osteoid becomes trapped when its neighbor osteoblasts place osteoid on top of the embedding cell.(11) However, there are several arguments against osteocytogenesis being a passive process. [Figure: Expression of markers during osteoblast-to-osteocyte ontogeny. The osteocyte appears to be the descendant of the matrix-producing osteoblast, which is a descendant of the mesenchymal stem cell known to express markers such as Stro1, CD29, CD105, CD166. Matrix-producing osteoblasts express Cbfa1 and Osterix, necessary for osteoblast differentiation, followed by alkaline phosphase and collagen, necessary for the production of osteoid. Osteocalcin is produced by the late osteoblast and continues to be expressed by the osteocyte. By some unknown mechanism, some designated cells begin to embed in osteoid and begin to extend dendritic projections, keeping connections with already embedded cells and cells on the bone surface. Molecules such as E11/gp38 and MT1-MMP appear to play a role in dendrite/canaliculi formation, whereas molecules such as destrin and CapG regulate the cytoskeleton. PHEX, MEPE, and DMP-1 regulate biomineralization and mineral metabolism, and FGF-23 regulates renal phosphate excretion. FGF-23 is elevated not only in osteocytes from hypophosphatemic animals but also in those of normal rats.(112) Sclerostin is a marker of the mature osteocyte and is a negative regulator of bone formation.(45) ORP150 may preserve viability of this cell in a hypoxic environment.(23)] One of the first changes to take place in the embedding cell is the formation of dendritic processes. The cell undergoes a dramatic transformation from a polygonal cell to a cell extending dendrites toward the mineralizing front, which is followed by dendrites extending to either the vascular space or bone surface. The cell, once embedded in bone, especially cortical bone, has a polarity, especially with regard to directionality of mineral formation. The osteoid osteocyte must do two major functions simultaneously: regulate mineralization and form connective dendritic processes. The osteoid osteocyte can control and regulate mineralization,(12) and Holmbeck and colleagues(13) have shown osteocytogenesis to be an active invasive process requiring cleavage of collagen and potentially other matrix molecules. Osteocytes in mice null for the metalloproteinase MT1-MMP have significantly reduced number and length of dendritic processes. MT1-MMP is a membrane-anchored proteinase that can cleave collagens type I, II, and III, fibrin, fibronectin, and other matrix molecules. In this mouse model, the almost complete lack of dendritic processes did not appear to affect viability or density of osteocytes in contrast to studies by Zhao and coworkers,(14) where osteocytes in a mouse model of collagenase-resistant type I collagen did show increased apoptosis. However, it was impossible to determine the effect of a lack of dendritic processes on either osteocyte function or the effect(s) on the skeleton because the MT1-MMP null mouse exhibits multiple defects such as dwarfism owing to a lack of MT1-MMP in other skeletal tissues.(15) Osteocyte morphology may be controlled by E11/gp38/podoplanin, a marker for the embedding osteoid osteocyte (Fig. 2). E11, also called podoplanin, OTS-8, gp38, or PA2.25, was first detected on the cell surface of osteocytes in rat bone(16,17) and odontoblasts in rat tooth.(18) It is also expressed in type I cells of rat lung and other tissues of brain, kidney, the lymphatic system, and skin. Application of fluid-flow shear stress on osteocyte-like MLO-Y4 cells increased the number and length of dendrites and was blocked by small interfering RNA against E11/gp38.(19) Conditional deletion in bone cells in vivo resulted in decreased canaliculi and increased trabecular bone.(20) In addition to E11, organized expression of tubulin, vimentin, and actin in cell bodies and dendrites of osteocytes is crucial to maintain their dendritic morphology.(21) Differences in distribution of fimbrin, villin, filamin, and spectrin, all actin-binding proteins, have been described accompanying the differentiation of osteoblasts to osteocytes,(22) as well as CapG and destrin, molecules necessary for cytoskeletal rearrangement.(23) Intriguingly, two groups of investigators have shown an increase in number of dendritic processes with skeletal age, suggesting that the already embedded osteocyte can either generate new processes or, alternatively, the newly embedded cells have a greater number of dendrites.(13,24) [Figure: Visualization of

Read the complete text